Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Hair Relaxer Lawsuits Moving Forward Simultaneously in Federal MDL and Various State Courts Lawyers are meeting today with the U.S. District Judge presiding over the litigation, to provide an update on the status of hair relaxer lawsuits being pursued throughout the country. November 12, 2024 Irvin Jackson Add Your Comments The U.S. District Judge presiding over all hair relaxer lawsuits will meet today with lawyers involved in the litigation, as a growing number of claims continue to be filed in both the federal and state court systems by women diagnosed with uterine cancer, endometrial cancer, ovarian cancer and other injuries allegedly caused by toxic chemicals in popular straighteners. Women began filing the complaints in late 2022, following the publication of a study that highlighted a link between hair relaxers and uterine cancer, finding that women who regularly used the products face a 156% increased risk compared to women who did not use them. Other studies have also found that hair relaxers increase the risk of ovarian cancer, as well as other injuries. Given common questions of fact and law raised in lawsuits brought throughout the federal court system, the litigation has been centralized in the Northern District of Illinois before U.S. Judge Mary Rowland since February 2023, for coordinated pretrial proceedings as part of a hair relaxer lawsuit MDL, or multidistrict litigation. There are currently just under 9,500 lawsuits pending in the federal MDL against the manufacturers of popular hair straighteners, like Dark & Lovely, Just for Me, Optimum Care, ORS Olive Oil and other brands, according to a docket update (PDF) posted by the U.S. Judicial Panel on Multidistrict Litigation (JPML) earlier this month. However, according to a joint status report (PDF) submitted last week by lawyers involved in the MDL, there are also another 300 complaints pending in various state courts, including Illinois, Georgia, New York and Pennsylvania. HAIR RELAXER COMPENSATION Did you or a loved one use hair relaxer products? Uterine cancer, endometrial cancer and ovarian cancer may be caused by chemicals in hair relaxer. See if you are eligible for benefits. Learn More SEE IF YOU QUALIFY FOR COMPENSATION HAIR RELAXER COMPENSATION Did you or a loved one use hair relaxer products? Uterine cancer, endometrial cancer and ovarian cancer may be caused by chemicals in hair relaxer. See if you are eligible for benefits. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Judge Rowland has scheduled a status conference for today, at which time the parties are expected to update the Court on the progress of resolving certain issues in the litigation, including pending motions to dismiss claims involving specific injuries, deposition protocols and progress establishing a “bellwether” process, where a small group of representative cases will be prepared for early trial dates to gauge how juries may interpret evidence and expert testimony that will be repeated throughout the litigation. As part of the coordinated management of the cases, the parties are currently engaged in a discovery process that will continue through most of 2025, involving the exchange of information relevant to all claims. Once that is complete, it is expected that Judge Rowland will hold a series of “bellwether” trials. While the outcomes of these trials will not have any binding impact on other claims, the average hair relaxer lawsuit payouts awarded by juries may influence eventual settlement negotiations. Of the thousands of claims filed, the parties have agreed that the litigation, and bellwether trials should focus on women with uterine cancer, endometrial cancer and ovarian cancer. As a result, plaintiffs’ attorneys moved to dismiss claims involving other injuries without prejudice in May, meaning that plaintiffs would be able to refile their lawsuits if they receive one of those three cancer diagnoses in the future. According to the joint status report, defendants have identified 451 such claims that may be ripe for dismissal. In November 2023, Judge Rowland ordered the parties to propose competing hair relaxer lawsuit bellwether trial plans, outlining a process for selecting a group of representative cases to go through case-specific discovery in preparation for early trial dates. However, the parties have been unable to agree on several key points regarding the selection of representative claims, as well as when the bellwether process should get underway. The status report indicates the parties will await a decision by the court on several dismissal motions before attempting to implement a bellwether process. Hair Relaxer Lawsuits Filed in State Courts The hair relaxer litigation is not limited to federal court, however, and there is a good chance a hair relaxer lawsuit filed at the state level could be the first to go to trial. According to the status report, there are 145 claims filed in Cook County, Illinois, where they have been consolidated before Judge Patrick T. Stanton. However, it is Judge Kathy M. Flanagan who is presiding over the trial calendar for the proceedings, and she is expected to eventually set trial dates for five hair relaxer lawsuits to go to trial, and may present trial dates at a hearing on November 26. She has directed plaintiffs to be ready to present their trial proposals. There are another 126 claims spread across three state courts in Georgia as well, 26 claims pending in Pennsylvania state courts, four in New York, and one in Delaware. Following coordinated discovery in the MDL and any early bellwether trials, if the parties fail to negotiate hair relaxer settlements for individuals diagnosed with uterine cancer, endometrial cancer, ovarian cancer and other complications, Judge Rowland may later remand each individual lawsuit directly filed in the MDL back to the U.S. District Court where it would have originated for a separate trial in the future. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Cancer, Endocrine Disruptors, Endometrial Cancer, Endometriosis, Hair Relaxer, Hair Straighteners, L'Oreal, Ovarian Cancer, Perm, Phthalates, Revlon, Uterine Cancer, Uterine Fibroids Find Out If You Qualify for Hair Relaxer Compensation More Hair Relaxer Lawsuit Stories MDL Judge To Weigh Hair Relaxer Cancer Evidence in Mid-2026 September 11, 2025 Uterine Cancer Cases Expected to ‘Increase Substantially’ Over Next 30 Years: Study July 8, 2025 Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” July 3, 2025 0 Comments LinkedInThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: yesterday) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025) Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: 2 days ago) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITReports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges (09/24/2025) Over 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (Posted: 3 days ago) A federal judge has called for more coordination between state and federal courts handling Depo shot lawsuits claiming the contraceptive causes brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (09/26/2025)Link Between Depo-Provera and Meningioma Brain Tumors Ignored by Pfizer, Plaintiffs Indicate (09/22/2025)
Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: yesterday) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)
Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: 2 days ago) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITReports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges (09/24/2025)
Over 1,300 Depo Shot Lawsuits Now Being Pursued by Women With Meningioma Tumors (Posted: 3 days ago) A federal judge has called for more coordination between state and federal courts handling Depo shot lawsuits claiming the contraceptive causes brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit Describes Left-Sided Numbness, Tingling Before Diagnosis (10/01/2025)Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (09/26/2025)Link Between Depo-Provera and Meningioma Brain Tumors Ignored by Pfizer, Plaintiffs Indicate (09/22/2025)